Weight Loss Maintenance
13 articles on Weight Loss Maintenance, researched and written by the Shotlee Editorial Team from primary sources.
Retatrutide Breakthrough: Can This Molecule Rival Gastric Bypass Surgery?
New data suggests Eli Lilly's retatrutide could deliver up to 28% weight loss, potentially rivaling bariatric surgery. Learn about efficacy and safety.
8 min read
Oral GLP-1s for Weight Loss Maintenance: A New Frontier
A groundbreaking study reveals that switching to an oral GLP-1 medication like orforglipron can help individuals maintain a significant portion of their weight loss achieved with injectable therapies, offering a new avenue for long-term obesity management.
6 min read
New Procedure May Combat Weight Regain After GLP-1s
Losing weight with GLP-1 medications like semaglutide and tirzepatide is a significant achievement, but maintaining that loss after stopping treatment presents a major challenge. A new experimental procedure, duodenal mucosal resurfacing (DMR), is showing remarkable potential in helping individuals keep the pounds off.
7 min read
New GLP-1 Playbook for Weight Loss: Shots to Pills Shift
Weight loss treatment is evolving with a new GLP-1 playbook: start with weekly injections for rapid results, then transition to convenient pills for maintenance. Eli Lilly's weight-loss tablet and oral Wegovy promise easier adherence, but with trade-offs in effectiveness and strict dosing rules. Doctors highlight the maintenance challenges that make this shift essential.
6 min read
ROOT Brands® Fills GLP-1 Gap with CRUSH™ & SCULPT™ After Ozempic® & Wegovy®
As millions using GLP-1 medications like Ozempic® and Wegovy® face post-treatment challenges such as muscle loss and weight regain, ROOT Brands® introduces CRUSH™ and SCULPT™. This cellular-first protocol supports metabolic function and lean muscle preservation without pharmaceuticals. Backed by science, it targets the 'GLP-1 gap' for long-term body composition success.
5 min read
What Happens to Your Body on Ozempic Without Exercising: Study Insights
Wondering what happens to your body when you take Ozempic without exercising? A recent study in Sports Medicine analyzed liraglutide users and found that while GLP-1 drugs promote weight loss, skipping exercise leads to poorer fitness outcomes. Exercise plus the drug delivers the best results for health and function.
5 min read
ARD-201 Trial: Maintaining Weight Loss After Ozempic, Wegovy
GLP-1 drugs like Ozempic and Wegovy deliver impressive weight loss, but regain is common after stopping. A new Phase 2 trial of oral ARD-201 aims to change that by regulating appetite via bitter taste receptors. Led by obesity expert Lawrence Cheskin at George Mason University, this study targets post-treatment weight maintenance.
5 min read
GLP-1 Discontinuation: Mixed Weight Loss Results in Real-World Study
A large real-world study from Cleveland Clinic reveals mixed outcomes after GLP-1 discontinuation: 55% of obese patients regained weight, while 45% maintained or continued losing. Many switched to alternative treatments, highlighting the need for ongoing obesity care. This data underscores gaps in long-term management and the role of nutritional support.
5 min read
What Happens After Stopping GLP-1 Drugs Like Ozempic? UK Study Findings
A new Cambridge study reveals that after stopping GLP-1 drugs like Ozempic and Wegovy, patients regain nearly 60% of lost weight within a year, with appetite returning rapidly. Researchers modeled long-term trends showing about 75% regain over time, emphasizing the need for lifestyle support. This comprehensive guide breaks down the findings and what they mean for patients.
6 min read
Ozempic Kickstart, Not Magic: How to Make Weight Loss Stick
Doctors publicly tout GLP-1 drugs like Ozempic for weight loss, but privately warn patients may need them lifelong. A systematic review of 48 studies reveals up to 60% weight regain after stopping. Here's how to use Ozempic as a kickstart and make weight loss permanent with lifestyle changes.
5 min read
Hit Weight Loss Goal on GLP-1s Like Ozempic? What Next?
GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have helped 1 in 8 U.S. adults lose 15-20% body weight. But after hitting your goal, what now? Dr. Amy J. Sheer shares proven steps for maintenance, plateaus, and long-term success.
8 min read
Tirzepatide vs Semaglutide: Weight Loss Duration After Stopping
GLP-1 medications like semaglutide and tirzepatide deliver impressive weight loss, but what happens when you stop? Pivotal trials reveal significant regain risks, underscoring obesity as a chronic condition. This guide breaks down the evidence and offers practical insights for sustained results.
4 min read
The Future of Ozempic: How the Food Sector is Adapting to Weight-Loss Drug Impacts on Consumption
The food industry is facing a significant challenge due to the rise of weight-loss drugs like Ozempic, which are altering consumer preferences. Companies are now innovating to cater to a new landscape of health-conscious consumers.
6 min read